IN2013CH05455A - - Google Patents

Download PDF

Info

Publication number
IN2013CH05455A
IN2013CH05455A IN5455CH2013A IN2013CH05455A IN 2013CH05455 A IN2013CH05455 A IN 2013CH05455A IN 5455CH2013 A IN5455CH2013 A IN 5455CH2013A IN 2013CH05455 A IN2013CH05455 A IN 2013CH05455A
Authority
IN
India
Prior art keywords
diastereomer
undesired
racemization
recycle
efficient
Prior art date
Application number
Other languages
English (en)
Inventor
Thatipally Suresh
Swamy Udutha Kumara
Bushan Kotala Mani
Lakshmi Narasimha Rao Dammalapati Venkata
Ramanjaneyulu Gorantla Seeta
Chava Satyanarayana
Original Assignee
Laurus Labs Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laurus Labs Private Ltd filed Critical Laurus Labs Private Ltd
Priority to IN5455CH2013 priority Critical patent/IN2013CH05455A/en
Priority to PCT/IN2014/000734 priority patent/WO2015079455A2/en
Publication of IN2013CH05455A publication Critical patent/IN2013CH05455A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
IN5455CH2013 2013-11-27 2014-11-27 IN2013CH05455A (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN5455CH2013 IN2013CH05455A (no) 2013-11-27 2014-11-27
PCT/IN2014/000734 WO2015079455A2 (en) 2013-11-27 2014-11-27 A recycling process for preparing tenofovir alafenamide diastereomers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN5455CH2013 IN2013CH05455A (no) 2013-11-27 2014-11-27

Publications (1)

Publication Number Publication Date
IN2013CH05455A true IN2013CH05455A (no) 2015-08-07

Family

ID=53199699

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5455CH2013 IN2013CH05455A (no) 2013-11-27 2014-11-27

Country Status (2)

Country Link
IN (1) IN2013CH05455A (no)
WO (1) WO2015079455A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107179355B (zh) * 2016-03-11 2021-08-10 广东东阳光药业有限公司 一种分离检测替诺福韦艾拉酚胺及其有关物质的方法
CN107655987B (zh) * 2017-09-08 2020-11-03 厦门蔚扬药业有限公司 一种替诺福韦艾拉酚胺及其异构体的hplc检测方法
CN111239285B (zh) * 2020-02-20 2020-10-09 北京阳光诺和药物研究有限公司 一种替诺呋韦艾拉酚胺中基因毒性杂质的含量检测方法
CN111189947B (zh) * 2020-03-30 2022-06-17 济南新科医药科技有限公司 一种分离检测富马酸丙酚替诺福韦异构体的分析方法
CN113970612B (zh) * 2020-07-22 2023-08-01 北京四环制药有限公司 一种高效液相色谱法测定丙酚替诺福韦有关物质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1466A (en) * 2000-07-21 2005-09-22 Gilead Sciences Inc Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same.
EP3333173B1 (en) * 2011-10-07 2019-06-26 Gilead Sciences, Inc. Methods for preparing anti-viral nucleotide analogs
EP2809323A1 (en) * 2012-02-03 2014-12-10 Gilead Sciences, Inc. Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections

Also Published As

Publication number Publication date
WO2015079455A3 (en) 2015-08-27
WO2015079455A2 (en) 2015-06-04

Similar Documents

Publication Publication Date Title
PH12018500718A1 (en) Compounds useful as modulators of trpm8
PH12017501042A1 (en) Anti-cd38 antibodies for treatment of acute myeloid leukemia
IN2014CH00247A (no)
EA201792503A1 (ru) Соль (s)-kck s-кетамина, соль (r)-kck s-кетамина и способы получения s-кетамина
IN2013MU00848A (no)
IN2013CH05455A (no)
IN2013MU03070A (no)
MX2017005630A (es) Metodo para preparar bifenilaminas a partir de azobencenos mediante catalisis de rutenio.
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
PL3445739T3 (pl) Proces destylacji mieszaniny aldehydów
EP3421604A4 (en) PROCESS FOR PRODUCTION OF L-AMINO ACID
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
MA40312A (fr) Composition pharmaceutique orale d'isotrétinoïne
MX361770B (es) Método para la preparación de 1-alquil-3-difluorometil-5-fluor-1h- pirazol-4-carbaldehídos y 1-alquil-3-difluorometil-5-fluor-1h-pira zol-4-carboxilatos.
PH12017501944A1 (en) Method of making a mercury based compound, mercury based compound, methods of using the mercury based compound and uses of the mercury based compound
IN2013MU01113A (no)
MY177218A (en) Method for producing specific ?,?-unsaturated aldehydes by rearrangement process
IN2015DN01814A (no)
EP3636631A4 (en) PROCESS FOR PRODUCING UNSATURATED NITRILE
MY187078A (en) Process of production of 7,8-dihydro-c15-aldehyde
IN2014CH01541A (no)
WO2017098520A8 (en) PROCESS FOR THE PREPARATION OF LABETALOL CHLORHYDRATE
IN2013CH05865A (no)
IN2013MU03768A (no)